China Opens One Of The World’s Largest Pharmaceutical Industry Platforms As API China 2026 And Co Located Mega Exhibitions Begin

API China 2026 was officially inaugurated today alongside co located industry exhibitions including PharmChina 2026, NHN...

May 13, 2026 | Wednesday | News
GSK enters exclusive collaboration with SBP Group to accelerate hepatitis B treatment in China

GSK plc has entered into an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its subsi...

May 13, 2026 | Wednesday | News
Taiwan's Bora Group buys MacroGenics' GMP manufacturing operations for $122.5 M

Taiwan-based Bora Pharmaceuticals announced that its Board of Directors has approved the acquisition of the GMP manufact...

May 12, 2026 | Tuesday | News
CEL-SCI enters strategic agreement with Amarox for commercialisation and distribution of Multikine in Saudi Arabia

US-baed CEL-SCI Corporation has signed a strategic partnership, distribution, and revenue sharing agreement with&nb...

May 12, 2026 | Tuesday | News
Hengrui Pharma and Bristol Myers Squibb to advance innovative medicines across oncology, hematology, immunology

China-based Hengrui Pharma and Bristol Myers Squibb (BMS) have announced the companies have entered into globa...

May 12, 2026 | Tuesday | News
Japan's Daiichi Sankyo unveils five-year business plan focused on oncology innovation

Japan-based Daiichi Sankyo has revealed its next Five-Year Business Plan (FY2026 - FY2030) that outlines how the company...

May 11, 2026 | Monday | News
China's SiranBio inks $1 B deal with GSK for metabolic and vascular disease treatment

Suzhou Siran Biotechnology has announced a worldwide exclusive license agreement with GSK (excluding mainland China, Hon...

May 8, 2026 | Friday | News
Waiv enters collaboration with Daiichi Sankyo to deliver AI-derived biomarkers for ADC programme

Waiv, formerly Owkin Dx, a Paris-based company catalysing artificial intelligence (AI) precision testing, has entered a ...

May 7, 2026 | Thursday | News
SGS launches GMP-compliant NMR testing for Chinese pharma industry

SGS, world’s leading Testing, Inspection and Certification company, has expanded its analytical capabilities in Ch...

May 7, 2026 | Thursday | News
Basel Area Business & Innovation inks new collaboration with Korean biopharma companies

Basel Area Business & Innovation, the strategic growth partner helping ventures in science and tech to land, launch ...

May 6, 2026 | Wednesday | News
UAE’s LIFEPharma signs MoU with AD Ports for $190 M pharma manufacturing platform

LIFEPharma, a part of VPS Healthcare and the UAE’s only USFDA-approved manufacturer, has signed a memorandum of un...

May 6, 2026 | Wednesday | News
Holista executes binding JV for collagen facility in Australia

Holista Colltech has entered into a binding Joint Venture (JV) agreement with Swang Chai Chuan (SCC) for the funding, de...

May 6, 2026 | Wednesday | News
Australia approves small interfering RNA medicine for Familial Chylomicronemia Syndrome

US-based Arrowhead Pharmaceuticals has announced that the Australian Therapeutic Goods Administration&nbs...

May 5, 2026 | Tuesday | News
Rockwell Automation and Cytiva join hands to accelerate digital transformation for biopharma companies

Cytiva, a Danaher company and a leader in the life sciences industry, and Rockwell Automation, Inc, the world&rsquo...

May 4, 2026 | Monday | News
Japan's Shionogi joins World Economic Forum and signs Davos Compact on Antimicrobial Resistance

Japan-based Shionogi & Co. has joined the World Economic Forum (WEF), and signed the Davos Compact on Antimicrobial ...

May 1, 2026 | Friday | News
China's Huahui Health and BeOne Medicines ink $1.9 B oncology deal

China-based startup Huahui Health has entered into a global exclusive option, license and collaboration agreement w...

May 1, 2026 | Friday | News
Taiwan's Formosa Pharma and Singapore Eye Research Institute partner to advance novel ophthalmic formulations for corneal diseases

Taiwan-based Formosa Pharmaceuticals, Inc. and the Singapore Eye Research Institute (SERI) have annoounced a strategic r...

May 1, 2026 | Friday | News
Emirates Drug Establishment gives nod to first nasal epinephrine spray

The Emirates Drug Establishment (EDE) has officially granted approval for EURneffy®, a novel epinephrine-based treat...

April 30, 2026 | Thursday | News
Ravidasvir receives approval in Thailand for treatment of Hepatitis C

In a historic step for the Egyptian pharmaceutical industry that reinforces its global leadership, the Thai Food and Dru...

April 30, 2026 | Thursday | News
Arcera Life Sciences inks long-term collaboration framework with Fosun Pharma

Arcera Life Sciences, a global life sciences company headquartered in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group...

April 29, 2026 | Wednesday | News
China gives marketing approval to world's first recombinant Botulinum Toxin Type A drug

Chongqing Claruvis Pharmaceutical, a subsidiary of MingMed Biotechnology, has announced that the China's National M...

April 29, 2026 | Wednesday | News
IMG Pharma enters into definitive agreement to acquire Matsumoto Pharmaceutical in Japan

IMG Pharmaceutical Co, a majority-owned subsidiary of IMG Japan, the Group's holding company, has entered into a definit...

April 27, 2026 | Monday | News
India and New Zealand sign historic Free Trade Agreement

India and New Zealand signed the India-New Zealand Free Trade Agreement (IN-NZ FTA) at Bharat Mandapam in New Delhi, on ...

April 27, 2026 | Monday | News
Novartis malaria treatment Coartem® Baby receives WHO prequalification

Novartis has announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) ...

April 26, 2026 | Sunday | News
AbbVie's largest-ever capital investment of $1.4 B to build pharma manufacturing campus in US

AbbVie has announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, N...

April 24, 2026 | Friday | News